NO20091141L - Pyrido (2,3-D) pyrimidinonforbindelser og deres anvendelse som P13 inhibitorer - Google Patents

Pyrido (2,3-D) pyrimidinonforbindelser og deres anvendelse som P13 inhibitorer

Info

Publication number
NO20091141L
NO20091141L NO20091141A NO20091141A NO20091141L NO 20091141 L NO20091141 L NO 20091141L NO 20091141 A NO20091141 A NO 20091141A NO 20091141 A NO20091141 A NO 20091141A NO 20091141 L NO20091141 L NO 20091141L
Authority
NO
Norway
Prior art keywords
inhibitors
pyrido
pyrimidinone compounds
compounds
pyrimidinone
Prior art date
Application number
NO20091141A
Other languages
English (en)
Other versions
NO342357B1 (no
Inventor
Mitchell David Nambu
Hengmiao Cheng
Mary Catherine Johnson
Jacqui Elizabet Hoffman
Robert Steven Kania
Phuong Thi Quy Le
Mason Alan Pairish
Dilip Bhumralkar
Klaus Ruprecht Dress
Michael Bruno Plewe
Khanh Tuan Tran
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of NO20091141L publication Critical patent/NO20091141L/no
Publication of NO342357B1 publication Critical patent/NO342357B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Abstract

Foreliggende oppfinnelse angår nye 4-metylpyridopyrimidinonforbindelser med formel (1), og salter derav, deres syntese og deres anvendelse som inhibitorer av fosfoinositid 3-kinase alfa (PI3-Koc).
NO20091141A 2006-09-15 2009-03-18 Pyrido-(2,3-d)-pyrimidinonforbindelser, farmasøytisk sammensetning og deres anvendelse som PI3-inhibitorer NO342357B1 (no)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US84506506P 2006-09-15 2006-09-15
US94785207P 2007-07-03 2007-07-03
US95262807P 2007-07-30 2007-07-30
PCT/IB2007/002578 WO2008032162A1 (en) 2006-09-15 2007-09-03 Pyrido (2, 3-d) pyrimidin0ne compounds and their use as pi3 inhibitors

Publications (2)

Publication Number Publication Date
NO20091141L true NO20091141L (no) 2009-03-31
NO342357B1 NO342357B1 (no) 2018-05-14

Family

ID=38859750

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20091141A NO342357B1 (no) 2006-09-15 2009-03-18 Pyrido-(2,3-d)-pyrimidinonforbindelser, farmasøytisk sammensetning og deres anvendelse som PI3-inhibitorer

Country Status (42)

Country Link
US (3) US7696213B2 (no)
EP (1) EP2074122B9 (no)
JP (1) JP4718637B2 (no)
KR (1) KR101099926B1 (no)
CN (1) CN101573358B (no)
AP (1) AP2710A (no)
AR (1) AR062785A1 (no)
AT (1) ATE514695T1 (no)
AU (1) AU2007297212B8 (no)
BR (1) BRPI0716749B8 (no)
CA (1) CA2663401C (no)
CL (1) CL2007002682A1 (no)
CR (1) CR10662A (no)
CU (1) CU23783B7 (no)
CY (1) CY1111911T1 (no)
DK (1) DK2074122T5 (no)
DO (1) DOP2009000039A (no)
EA (1) EA016388B1 (no)
ES (1) ES2366489T3 (no)
GE (1) GEP20115306B (no)
GT (1) GT200700077A (no)
HK (1) HK1138589A1 (no)
HN (1) HN2007000267A (no)
HR (1) HRP20110621T2 (no)
IL (1) IL197243A (no)
MA (1) MA30709B1 (no)
ME (1) MEP8009A (no)
MX (1) MX2009002927A (no)
MY (1) MY146420A (no)
NI (1) NI200900032A (no)
NO (1) NO342357B1 (no)
NZ (1) NZ575167A (no)
PE (1) PE20080670A1 (no)
PL (1) PL2074122T3 (no)
PT (1) PT2074122E (no)
RS (2) RS20090104A (no)
SI (1) SI2074122T1 (no)
TN (1) TN2009000085A1 (no)
TW (1) TWI334353B (no)
UY (1) UY30588A1 (no)
WO (1) WO2008032162A1 (no)
ZA (1) ZA200901477B (no)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2366489T3 (es) * 2006-09-15 2011-10-20 Pfizer Products Inc. Compuesto de pirido (2,3-d) piridinona y sus uso como inhibidores de pi3.
MY150697A (en) * 2007-04-10 2014-02-28 Exelixis Inc Methods of treating cancer using pyridopyrimdinone inhibitors of p13k alpha
AU2008239596B2 (en) * 2007-04-11 2013-08-15 Exelixis, Inc. Pyrido [2,3-D] pyrimidin-7-one compounds as inhibitors of PI3K-alpha for the treatment of cancer
WO2010006225A1 (en) * 2008-07-11 2010-01-14 Novartis Ag Combination of (a) a phosphoinositide 3-kinase inhibitor and (b) a modulator of ras/raf/mek pathway
US8697694B2 (en) 2008-08-20 2014-04-15 Merck Sharp & Dohme Corp. Substituted pyridine and pyrimidine derivatives and their use in treating viral infections
EP2326626B1 (en) 2008-08-20 2013-10-16 Merck Sharp & Dohme Corp. Ethenyl-substituted pyridine and pyrimidine derivatives and their use in treating viral infections
EP2326628A1 (en) 2008-08-20 2011-06-01 Schering Corporation Azo-substituted pyridine and pyrimidine derivatives and their use in treating viral infections
CA2734487A1 (en) 2008-08-20 2010-02-25 Southern Research Institute Ethynyl-substituted pyridine and pyrimidine derivatives and their use in treating viral infections
EP2350070A1 (en) * 2008-09-30 2011-08-03 Exelixis, Inc. Pyridopyrimidinone inhibitors of pi3k and mtor
US10010439B2 (en) 2010-06-13 2018-07-03 Synerz Medical, Inc. Intragastric device for treating obesity
US9526648B2 (en) 2010-06-13 2016-12-27 Synerz Medical, Inc. Intragastric device for treating obesity
US8628554B2 (en) 2010-06-13 2014-01-14 Virender K. Sharma Intragastric device for treating obesity
US10420665B2 (en) 2010-06-13 2019-09-24 W. L. Gore & Associates, Inc. Intragastric device for treating obesity
TWI441824B (zh) 2010-12-16 2014-06-21 Hoffmann La Roche 三環ｐｉ３ｋ抑制劑化合物及其使用方法
US8664230B2 (en) * 2011-03-17 2014-03-04 The Asan Foundation Pyridopyrimidine derivatives and use thereof
TW201306842A (zh) * 2011-06-15 2013-02-16 Exelixis Inc 使用ｐｉ３ｋ／ｍｔｏｒ吡啶並嘧啶酮抑制劑及苯達莫司汀及／或利妥昔單抗治療惡性血液疾病之組合療法
BR112014004587A2 (pt) 2011-08-31 2017-03-14 Novartis Ag combinações sinérgicas de inibidores de pi3k- e de mek
CN104829609B (zh) * 2014-02-11 2016-08-03 北大方正集团有限公司 取代的吡啶并嘧啶化合物及其制备方法和应用
CA2954189A1 (en) 2014-07-26 2016-02-04 Sunshine Lake Pharma Co., Ltd. 2-amino-pyrido[2,3-d]pyrimidin-7(8h)-one derivatives as cdk inhibitors and uses thereof
CN105330699B (zh) * 2014-08-13 2018-12-04 山东汇睿迪生物技术有限公司 一种含磷吡啶并[2,3-d]嘧啶-7-酮类化合物或其药学上可接受的盐、药物组合物及其应用
WO2016055907A1 (en) 2014-10-10 2016-04-14 Pfizer Inc. Synergistic auristatin combinations
EP3302565B1 (en) 2015-06-04 2019-11-06 Pfizer Inc Solid dosage forms of palbociclib
US10779980B2 (en) 2016-04-27 2020-09-22 Synerz Medical, Inc. Intragastric device for treating obesity
JP2019519593A (ja) 2016-07-06 2019-07-11 ザ・リージェンツ・オブ・ザ・ユニバーシティ・オブ・ミシガンＴｈｅ Ｒｅｇｅｎｔｓ Ｏｆ Ｔｈｅ Ｕｎｉｖｅｒｓｉｔｙ Ｏｆ Ｍｉｃｈｉｇａｎ ＭＥＫ／ＰＩ３Ｋ及びｍＴＯＲ／ＭＥＫ／ＰＩ３Ｋ生物学的経路の多官能性阻害剤、並びに同多官能性阻害剤を用いた治療方法
PE20190475A1 (es) 2016-08-15 2019-04-04 Pfizer Inhibidores de cdk2/4/6
WO2019157516A1 (en) 2018-02-12 2019-08-15 resTORbio, Inc. Combination therapies
KR20210021534A (ko) 2018-06-15 2021-02-26 나비토르 파마슈티칼스 인코포레이티드 라파마이신 유사체 및 이의 용도
US20220220103A1 (en) * 2018-12-28 2022-07-14 Spv Therapeutics Inc. Cyclin-dependent kinase inhibitors
US20230048132A1 (en) * 2018-12-28 2023-02-16 Spv Therapeutics Inc. Cyclin-dependent kinase inhibitors
US11583538B2 (en) 2019-04-08 2023-02-21 Venenum Biodesign, LLC Substituted pyrrolo[1,2-a]pyrazines and pyrrolo[1,2-a][1,4]diazepines as TREX1 inhibitors
US11819476B2 (en) 2019-12-05 2023-11-21 Janssen Pharmaceutica Nv Rapamycin analogs and uses thereof
WO2021139775A1 (zh) * 2020-01-10 2021-07-15 江苏先声药业有限公司 吡啶酮化合物及应用
WO2022075974A1 (en) * 2020-10-06 2022-04-14 Venenum Biodesign, LLC Cyclic trex1 inhibitors
MX2023005747A (es) 2020-11-18 2023-07-28 Deciphera Pharmaceuticals Llc Inhibidores de gcn2 y perk quinasas y metodos de uso de los mismos.
WO2023092104A1 (en) * 2021-11-18 2023-05-25 Onconova Therapeutics, Inc. Methods and compositions for treating cancer

Family Cites Families (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5264437A (en) * 1992-03-20 1993-11-23 Syntex (U.S.A.) Inc. Optionally substituted pyrido[2,3-d]pyridine-2,4(1H,3H)-diones and pyrido[2,]pyrimidine-2(1H,3H)-ones
TJ342B (en) 1994-11-14 2002-10-06 Warner Lambert Co Derivatives of 6-aryl pyrido Ä2,3-dÜ pyrimidines and naphthyridines pharmaceutical composition possess inhibiting effect of cellular proliferation pr ovoking protein tyrosine kinase and method of inhibiting cellular proliferation
CN1177960A (zh) * 1995-03-10 1998-04-01 圣诺菲药品有限公司 6－取代的吡唑并[3,4－d]嘧啶－4－酮及其组合物和使用方法
IL117923A (en) 1995-05-03 2000-06-01 Warner Lambert Co Anti-cancer pharmaceutical compositions containing polysubstituted pyrido¬2,3-d¾pyrimidine derivatives and certain such novel compounds
US5925761A (en) 1997-02-04 1999-07-20 Sepracor Inc. Synthesis of terfenadine and derivatives
JP2001509805A (ja) 1997-02-05 2001-07-24 ワーナー−ランバート・コンパニー 細胞増殖阻害剤としてのピリド〔２，３−ｄ〕ピリミジンおよび４−アミノピリミジン
US6498163B1 (en) 1997-02-05 2002-12-24 Warner-Lambert Company Pyrido[2,3-D]pyrimidines and 4-aminopyrimidines as inhibitors of cellular proliferation
GB9904932D0 (en) 1999-03-04 1999-04-28 Glaxo Group Ltd Composition and method for preventing/reducing the severity of side effects of chemotherapy and/or radiation therapy
CZ20022521A3 (cs) 2000-01-27 2003-02-12 Warner-Lambert Company Pyridopyrimidinonové deriváty pro léčení neurodegenerativních onemocnění
DZ3308A1 (fr) 2000-03-06 2001-09-27 Warner Lambert Co Inhibiteurs de tyrosine kinase a base de 5-alkylpyrido [2,3-d] pyrimidines
JP3649395B2 (ja) 2000-04-27 2005-05-18 山之内製薬株式会社 縮合ヘテロアリール誘導体
CA2438294C (en) 2001-02-26 2008-10-21 Tanabe Seiyaku Co., Ltd. Pyridopyrimidine or naphthyridine derivative
US7019002B2 (en) * 2001-12-11 2006-03-28 Pharmacia & Upjohn, S.P.A. Pyridopyrimidinones derivatives as telomerase inhibitors
IL162721A0 (en) 2002-01-22 2005-11-20 Warner Lambert Co 2-(Pyridin-2-ylamino)-pyridoÄ2,3-dÜpyrimidin-7-ones
JP2003321472A (ja) 2002-02-26 2003-11-11 Takeda Chem Ind Ltd Ｇｒｋ阻害剤
US7629350B2 (en) 2002-04-19 2009-12-08 Smithkline Beecham Corporation Compounds
MXPA04010983A (es) 2002-05-06 2005-02-14 Genelabs Tech Inc Derivados de nucleosidos para tratar infecciones por el virus de la hepatitis c.
JP2004083587A (ja) 2002-08-06 2004-03-18 Tanabe Seiyaku Co Ltd 医薬組成物
US7098332B2 (en) * 2002-12-20 2006-08-29 Hoffmann-La Roche Inc. 5,8-Dihydro-6H-pyrido[2,3-d]pyrimidin-7-ones
JP2004203751A (ja) 2002-12-24 2004-07-22 Pfizer Inc 置換６，６−ヘテロ二環式誘導体
WO2004063195A1 (en) 2003-01-03 2004-07-29 Sloan-Kettering Institute For Cancer Research Pyridopyrimidine kinase inhibitors
WO2004089930A1 (en) 2003-04-02 2004-10-21 Imclone Systems Incorporated 4-fluoroquinolone derivatives and their use as kinase inhibitors
WO2005040337A2 (en) 2003-05-20 2005-05-06 The Regents Of The University Of California METHODS FOR BINDING AGENTS TO β-AMYLOID PLAQUES
AU2004255934B2 (en) 2003-07-11 2010-02-25 Warner-Lambert Company Llc Isethionate salt of a selective CDK4 inhibitor
CN1867334A (zh) 2003-07-22 2006-11-22 詹森药业有限公司 作为c－fms激酶抑制剂的喹啉酮衍生物
US7160888B2 (en) * 2003-08-22 2007-01-09 Warner Lambert Company Llc [1,8]naphthyridin-2-ones and related compounds for the treatment of schizophrenia
CA2553785C (en) 2004-02-14 2011-02-08 Irm Llc Compounds and compositions as protein kinase inhibitors
EP1718645A1 (en) 2004-02-18 2006-11-08 Warner-Lambert Company LLC 2-(pyridin-3-ylamino)-pyrido 2,3-d pyrimidin-7-ones
WO2005094830A1 (en) 2004-03-30 2005-10-13 Pfizer Products Inc. Combinations of signal transduction inhibitors
WO2005105097A2 (en) 2004-04-28 2005-11-10 Gpc Biotech Ag Pyridopyrimidines for treating inflammatory and other diseases
CA2563669A1 (en) * 2004-05-04 2005-11-10 Warner-Lambert Company Llc Pyrrolyl substituted pyrido[2,3-d]pyrimidin-7-ones and derivatives thereof as therapeutic agents
EP1761281A1 (en) 2004-06-04 2007-03-14 Pfizer Products Incorporated Method for treating abnormal cell growth
WO2006021547A1 (de) 2004-08-26 2006-03-02 Boehringer Ingelheim International Gmbh Pteridinone als plk (polo like kinase) inhibitoren
US7608594B2 (en) 2004-11-03 2009-10-27 University Of Kansas Novobiocin analogues as anticancer agents
CA2590294A1 (en) 2004-12-13 2006-06-22 Sunesis Pharmaceuticals, Inc. Pyrido pyrimidinones, dihydro pyrimido pyrimidinones and pteridinones useful as raf kinase inhibitors
US20060142312A1 (en) 2004-12-23 2006-06-29 Pfizer Inc C6-aryl and heteroaryl substituted pyrido[2,3-D] pyrimidin-7-ones
WO2007044698A1 (en) * 2005-10-07 2007-04-19 Exelixis, Inc. PYRIDOPYRIMIDINONE INHIBITORS OF PI3Kα
NZ566903A (en) * 2005-10-07 2011-09-30 Exelixis Inc Pyrido (2,3-D) pyrimidinone compounds and their use as PI3 inhibitors
EP1872922A1 (en) * 2006-06-27 2008-01-02 Nederlandse Organisatie voor Toegepast-Natuuurwetenschappelijk Onderzoek TNO Method and apparatus for manufacturing a polymeric article
AU2007284562B2 (en) 2006-08-16 2013-05-02 Exelixis, Inc. Using PI3K and MEK modulators in treatments of cancer
ES2366489T3 (es) 2006-09-15 2011-10-20 Pfizer Products Inc. Compuesto de pirido (2,3-d) piridinona y sus uso como inhibidores de pi3.
BRPI0808772A2 (pt) * 2007-03-14 2014-08-12 Exelixis Inc Inibidores da via de hedgehog
AU2008239596B2 (en) 2007-04-11 2013-08-15 Exelixis, Inc. Pyrido [2,3-D] pyrimidin-7-one compounds as inhibitors of PI3K-alpha for the treatment of cancer
EP2350070A1 (en) 2008-09-30 2011-08-03 Exelixis, Inc. Pyridopyrimidinone inhibitors of pi3k and mtor
EP2557923A4 (en) * 2010-04-16 2013-10-23 Curis Inc TREATMENT OF CANCER DISORDERS WITH K-RAS MUTATIONS

Also Published As

Publication number Publication date
US8633204B2 (en) 2014-01-21
ES2366489T3 (es) 2011-10-20
KR101099926B1 (ko) 2011-12-28
AU2007297212B8 (en) 2011-04-28
CN101573358A (zh) 2009-11-04
AP2710A (en) 2013-07-30
BRPI0716749B8 (pt) 2021-05-25
UY30588A1 (es) 2008-05-02
ATE514695T1 (de) 2011-07-15
US20100137279A1 (en) 2010-06-03
EP2074122B9 (en) 2013-09-11
US7696213B2 (en) 2010-04-13
MEP8009A (en) 2011-12-20
EP2074122B1 (en) 2011-06-29
EA200970207A1 (ru) 2009-08-28
MY146420A (en) 2012-08-15
PE20080670A1 (es) 2008-06-14
DK2074122T5 (da) 2014-03-17
CY1111911T1 (el) 2015-11-04
RS20090104A (en) 2010-06-30
AU2007297212A1 (en) 2008-03-20
GT200700077A (es) 2009-08-03
CA2663401A1 (en) 2008-03-20
SI2074122T1 (sl) 2011-10-28
EP2074122A1 (en) 2009-07-01
HN2007000267A (es) 2011-02-25
HRP20110621T1 (en) 2011-09-30
DK2074122T3 (da) 2011-08-15
NO342357B1 (no) 2018-05-14
WO2008032162A8 (en) 2009-03-26
US8273755B2 (en) 2012-09-25
MA30709B1 (fr) 2009-09-01
CA2663401C (en) 2011-07-12
BRPI0716749A2 (pt) 2014-02-18
NZ575167A (en) 2010-10-29
CU23783B7 (es) 2012-02-15
HRP20110621T2 (hr) 2013-12-06
JP4718637B2 (ja) 2011-07-06
AP2009004790A0 (en) 2009-04-30
ZA200901477B (en) 2010-07-28
JP2010503653A (ja) 2010-02-04
EA016388B1 (ru) 2012-04-30
RS51927B (en) 2012-02-29
AU2007297212B2 (en) 2011-04-14
CR10662A (es) 2009-04-17
IL197243A (en) 2013-07-31
GEP20115306B (no) 2011-10-10
KR20090040389A (ko) 2009-04-23
BRPI0716749B1 (pt) 2020-10-06
US20120309775A1 (en) 2012-12-06
TN2009000085A1 (fr) 2010-08-19
NI200900032A (es) 2010-05-14
TW200820972A (en) 2008-05-16
PT2074122E (pt) 2011-08-24
IL197243A0 (en) 2009-12-24
CL2007002682A1 (es) 2008-04-04
AR062785A1 (es) 2008-12-03
CU20090040A7 (es) 2011-07-11
ES2366489T9 (es) 2013-12-27
US20080090801A1 (en) 2008-04-17
CN101573358B (zh) 2012-05-30
PL2074122T3 (pl) 2011-10-31
HK1138589A1 (en) 2010-08-27
DOP2009000039A (es) 2015-12-15
TWI334353B (en) 2010-12-11
MX2009002927A (es) 2009-03-31
WO2008032162A1 (en) 2008-03-20

Similar Documents

Publication Publication Date Title
NO20091141L (no) Pyrido (2,3-D) pyrimidinonforbindelser og deres anvendelse som P13 inhibitorer
NO20082090L (no) Pyridopyrimidinoninhibitorer av P13K alfa
NO20073791L (no) Pyrazolylaminopyridinderivater anvendbare som kinaseinhibitorer
NO20063468L (no) Triazolforbindelser og deres anvendelse som metabotrofe glutamatreseptorantagonister
NO20063470L (no) Tetrazolforbindelser og deres anvendelse av metabotrofe glutamatreseptorantagonister
CO6321276A2 (es) Derivados de tiazol usados como inhibidores de pi3- cinasa
MX2013006101A (es) Compuestos heterociclicos nitrogenados sustituidos fusionados en posicion 6,6 y usos de los mismos.
SMAP201100019A (it) Composti organici.
EA200801608A1 (ru) Производные бензимидазолонкарбоновой кислоты
WO2009016460A3 (en) Pyrazole compounds and their use as raf inhibitors
NO20083909L (no) Bisykliske benzimidazolforbindelser, og deres anvendelse som metabotropiske glutamatreseptorforsterkere
NO20063469L (no) Polyeheterosykliske forbindelser og deres anvendelse som metabotrofe glutamat reseptorantagonister
NO20075624L (no) Nye histamin H3-reseptorligander og deres terapeutiske anvendelser
NO20063821L (no) Kinolinderivater for anvendelse som mykobakterielle inhibitorer
NO20075406L (no) Pyrimidindionerivater som prokineticin-2-reseprorantagonister
UA107784C2 (en) Inhibitor of melanin production
NO20085107L (no) Spirosykliske nitriler som proteaseinhibitorer
NO20083708L (no) 4-Fenyl-tiazol-5-karboksylsyre og 4-fenyl-tiazol-5-karboksylmider som PLK1-inhibitorer
NO20060718L (no) Substituerte tiofoner og deres anvendelse
DK1819704T3 (da) Pyrrolopyridin-2-carboxylsyre-amid-derivat anvendelig som inhibitor af glycogenphosphorylase
NO20082589L (no) Nye indolizinderivater, fremgangsmate for fremstilling av samme og terapeutiske sammensetninger som inbefatter samme
UA95113C2 (en) Pyrido (2,3-d) pyrimidin0ne compounds and their use as pi3 inhibitors
NO20064410L (no) Fremgangsmate for fremstilling av tryptaseinhibitorer
TH95062B (th) อนุพันธ์ไซโคลเฮกซิล พิเพอราซินิล เมทธาโนน
HK1136288A1 (no)

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees